![](https://endpts.com/wp-content/uploads/2022/01/Eric-Murphy-Alterome-tile-scaled.jpg)
Eric Murphy (Kinnate)
OrbiMed takes point on a new biotech launch, but almost everything remains secret for now
If you missed the news of a new company launch backed by blue-chip investor OrbiMed early Wednesday morning, that was by design.
Alterome Therapeutics quietly …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.